Evidence map›Paper›PMID 31171824›Full record

ArticleScientific reports2019

Development of antiseptic adaptation and cross-adapatation in selected oral pathogens in vitro.

Tim Verspecht, Esteban Rodriguez Herrero, Ladan Khodaparast, Laleh Khodaparast, Nico Boon, Kristel Bernaerts, Marc Quirynen, Wim Teughels

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Compatibility of toothpastes with probiotics for periodontal health: anFrontiers in cellular and infection microbiology · 2026
    Article
  5. Impact ofFrontiers in oral health · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Activity of Antiseptics AgainstAntibiotics (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. The Antimicrobial Potential of the Hop (Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  15. Evaluation of aJournal of oral microbiology · 2024
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tim VerspechtDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Kapucijnenvoer 33, 3000, Leuven, Belgium.
Esteban Rodriguez HerreroDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Kapucijnenvoer 33, 3000, Leuven, Belgium.
Ladan KhodaparastSwitch Laboratory, VIB Center for Brain and Disease Research, Herestraat 49, 3000, Leuven, Belgium.
Laleh KhodaparastSwitch Laboratory, VIB Center for Brain and Disease Research, Herestraat 49, 3000, Leuven, Belgium.
Nico BoonCenter for Microbial Ecology and Technology (CMET), Ghent University (UGent), Coupure links 653, 9000, Gent, Belgium.
Kristel BernaertsBio- and Chemical Systems Technology, Reactor Engineering and Safety, Department of Chemical Engineering, University of Leuven (KU Leuven), Leuven Chem&Tech, Celestijnenlaan 200F (bus 2424), 3001, Leuven, Belgium.
Marc QuirynenDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Kapucijnenvoer 33, 3000, Leuven, Belgium.
Wim TeughelsDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Kapucijnenvoer 33, 3000, Leuven, Belgium. wim.teughels@med.kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is evidence that pathogenic bacteria can adapt to antiseptics upon repeated exposure. More alarming is the concomitant increase in antibiotic resistance that has been described for some pathogens. Unfortunately, effects of adaptation and cross-adaptation are hardly known for oral pathogens, which are very frequently exposed to antiseptics. Therefore, this study aimed to determine the in vitro increase in minimum inhibitory concentrations (MICs) in oral pathogens after repeated exposure to chlorhexidine or cetylpyridinium chloride, to examine if (cross-)adaptation to antiseptics/antibiotics occurs, if (cross-)adaptation is reversible and what the potential underlying mechanisms are. When the pathogens were exposed to antiseptics, their MICs significantly increased. This increase was in general at least partially conserved after regrowth without antiseptics. Some of the adapted species also showed cross-adaptation, as shown by increased MICs of antibiotics and the other antiseptic. In most antiseptic-adapted bacteria, cell-surface hydrophobicity was increased and mass-spectrometry analysis revealed changes in expression of proteins involved in a wide range of functional domains. These in vitro data shows the adaptation and cross-adaptation of oral pathogens to antiseptics and antibiotics. This was related to changes in cell surface hydrophobicity and in expression of proteins involved in membrane transport, virulence, oxidative stress protection and metabolism.

Indexed as

Drug Resistance, Multiple, BacterialAdaptation, BiologicalAggregatibacter actinomycetemcomitansAnti-Infective Agents, LocalBiological TransportCell MembraneCetylpyridiniumChlorhexidineDisinfectantsDrug Resistance, MicrobialFusobacterium nucleatumHydrophobic and Hydrophilic InteractionsMass SpectrometryMicrobial Sensitivity TestsOxidative StressPorphyromonas gingivalisAnti-Infective Agents, LocalCetylpyridiniumChlorhexidineDisinfectants

Identifiers

PMID31171824
PMCPMC6554408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.